Let’s be real and stop pretending
During her appearance on Watch What Happens Live with Andy Cohen on June 8th, renowned actress Amy Schumer expressed her disappointment with celebrities for their lack of honesty regarding the use of type 2 diabetes medication as a weight loss trend in Hollywood. Schumer, known for her role in the movie Trainwreck, openly criticized the industry for perpetuating this unhealthy practice without acknowledging its true purpose.
During her appearance on Watch What Happens Live with Andy Cohen on June 8th, Amy Schumer vented her frustration, passionately expressing, “It seems like everyone and their mom is going to give it a try. The problem is that everyone has been dishonest, claiming it’s just about eating smaller portions. Come on, enough with the lies. Either you’re using medications like Ozempic or similar ones, or you’ve had some cosmetic work done. Let’s be real and stop pretending.”
Unlike others, Amy emphasized her transparency regarding medical procedures, saying, “Be real with the people. When I got lipo, I said I got lipo.”
During the interview, Amy Schumer made a candid admission, revealing that she had personally experimented with Ozempic approximately a year ago. However, she found the experience to be unsustainable and detrimental to her cherished moments with her four-year-old son, Gene, and her husband, Chris Fischer. Reflecting on that time, she shared, “I was one of those individuals who felt incredibly unwell and couldn’t engage in playtime with my son. I was extremely thin, and even when he threw a ball at me, I couldn’t fully participate.”
Amy Schumer is not the sole celebrity who has been transparent about her use of Ozempic. In fact, just last month, Golnesa “GG” Gharachedaghi openly discussed her utilization of injection shots containing Semaglutide, the generic variant of the weight-loss medication. Golnesa firmly believes that there is no need to conceal the use of such medication or cosmetic procedures, as sharing personal experiences can be beneficial for others who are considering similar options. By being open about these topics, she aims to provide support and guidance to those interested in exploring these avenues.
Following the disclosures, a spokesperson from the pharmaceutical company Novo Nordisk provided clarification on the matter. They emphasized that Ozempic is not authorized or intended for long-term weight management purposes. Instead, the medication is specifically approved for the treatment of type 2 diabetes, aiming to enhance blood sugar levels and lower the risk of significant cardiovascular events in adult patients diagnosed with the condition. The representative’s statement underscores the importance of using medications for their intended purposes and consulting with healthcare professionals for appropriate medical advice.
